Evidence map›Paper›PMID 42576822›Full record

ArticleSustainable microbiology2026

Policy in Practice: How to do the Nagoya Protocol: common misconceptions, challenges and best practices for access and benefit-sharing compliance.

Davide Faggionato, Melania Muñoz-García, Tanja Kostic, Mariana L Ferrari, Pascale Vonaesch, Mathilde Poyet, Perrine Portier, Matthew J Ryan, Djamila Djeddour, Cornelia Stumptner and 10 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Sustainable microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Davide FaggionatoLeibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, Department of Science Policy & Internationalisation, Inhoffenstraße 7B, 38124 Braunschweig, Germany.ORCID https://orcid.org/0000-0003-0877-5479
Melania Muñoz-GarcíaLeibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, Department of Science Policy & Internationalisation, Inhoffenstraße 7B, 38124 Braunschweig, Germany.ORCID https://orcid.org/0000-0002-8313-5511
Tanja KosticCenter for Health & Bioresources, AIT Austrian Institute of Technology, Bioresources Unit,, Konrad Lorenz Strasse 24, 3430 Tulln, Austria.ORCID https://orcid.org/0000-0003-4972-4141
Mariana L FerrariInstitut Pasteur, Université Paris Cité, Biological Resource Center of Institut Pasteur, F-75015 Paris, France.ORCID https://orcid.org/0000-0002-0441-9242
Pascale VonaeschUniversity of Lausanne, Department of Fundamental Microbiology, UNIL-Sorge, 1015 Lausanne, Switzerland.ORCID https://orcid.org/0000-0002-1064-6505
Mathilde PoyetKiel University, Institute of Experimental Medicine,, 24105 Kiel, Germany.ORCID https://orcid.org/0000-0001-6905-9017
Perrine PortierMicrobial Resource Research Infrastructure (MIRRI-ERIC), Headquarters 4700-000 Braga, Portugal.ORCID https://orcid.org/0000-0003-1033-6731
Matthew J RyanCABI, Silwood Park, Buckhurst Road, Ascot, Berkshire SL5 7PY, United Kingdom.ORCID https://orcid.org/0000-0002-3689-6609
Djamila DjeddourCABI, Silwood Park, Buckhurst Road, Ascot, Berkshire SL5 7PY, United Kingdom.ORCID https://orcid.org/0000-0002-1421-4101
Cornelia StumptnerDiagnostic & Research Centre for Molecular Biomedicine, Medical University of Graz, Diagnostic & Research Institute of Pathology, Neue Stiftingtalstrasse 6, 8010 Graz, Austria.ORCID https://orcid.org/0000-0002-4364-9710
Giovanna Cristina VareseMicrobial Resource Research Infrastructure (MIRRI-ERIC), Headquarters 4700-000 Braga, Portugal.ORCID https://orcid.org/0000-0002-1455-6208
Aurora ZuzuarreguiMicrobial Resource Research Infrastructure (MIRRI-ERIC), Headquarters 4700-000 Braga, Portugal.ORCID https://orcid.org/0000-0003-2980-8321
Mathieu GroussinGlobal Microbiome Conservancy.ORCID https://orcid.org/0000-0002-0942-7217
Michael SchloterHelmholtz Center Munich-German Research Center for Environmental Health, 85764 Neuherberg, Germany.ORCID https://orcid.org/0000-0003-1671-1125
Robert D FinnEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, CB10 1SD Hinxton, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0001-8626-2148
Aylin S HaasLeibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, Department of Science Policy & Internationalisation, Inhoffenstraße 7B, 38124 Braunschweig, Germany.ORCID https://orcid.org/0000-0003-3067-827X
Ian ProbertSorbonne Université, CNRS, FR2424, Roscoff Culture Collection, Roscoff 29680, Station Biologique de Roscoff, France.ORCID https://orcid.org/0000-0002-1643-1759
Gerard VerkleyWesterdijk Fungal Biodiversity Institute, Uppsalalaan 8, 3584 CT Utrecht, Netherlands.ORCID https://orcid.org/0000-0001-6575-2439
Jörg OvermannLeibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, Inhoffenstraße 7B, 381124 Braunschweig, Germany, Microbial Ecology and Diversity.ORCID https://orcid.org/0000-0003-3909-7201
Amber H ScholzLeibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, Department of Science Policy & Internationalisation, Inhoffenstraße 7B, 38124 Braunschweig, Germany.ORCID https://orcid.org/0000-0002-3461-0881

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Nagoya Protocol establishes an international framework for access and benefit-sharing including for microbial research. Yet many microbiologists have only a vague understanding of what the Nagoya Protocol requires and are unsure how to navigate its complexities, despite the fact that non-compliance can have significant legal consequences and far-reaching reputational and legal impacts. This paper discusses common misconceptions and practical challenges that microbiologists may encounter when complying with the Nagoya Protocol and a step-by-step guide on how to "do" the Nagoya Protocol. We present three case studies to showcase real-life experiences and provide best practice principles for access and benefit-sharing while fostering biodiversity conservation, equitable collaboration, and sustainable innovation.

Indexed as

access and benefit-sharingassociated traditional knowledgecomplianceConvention on Biological Diversitygenetic resourceNagoya Protocol

Identifiers

PMID42576822
PMCPMC13375289

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.